2,451 followers
Purpose: The CD52-targeted antibody alemtuzumab induces major clinical responses in a group of patients with... http://t.co/yF1e0MJNkA
Purpose: The CD52-targeted antibody alemtuzumab induces major clinical responses in a group of patients with... http://t.co/yF1e0MJNkA
Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q- Patie http://t.co/0cLOkjMURy http://t.co/1kv8RaZBGe